Search research articles
Contact Us
Filters
Showing results (721-730 of 1,009) with videos related to
Page
of 101
Sort By:
The Journal of Biological Chemistry
|
May 27, 2010
Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling
Clarissa S Craft, Wei Zou, Marcus Watkins, et al.
Arthritis and Rheumatism
|
August 20, 2010
Musculoskeletal disease burden of hereditary hemochromatosis
Enijad Sahinbegovic, Tomáš Dallos, Elmar Aigner, et al.
Annals of the Rheumatic Diseases
|
August 4, 2010
Validation of a radiographic scoring system for haemochromatosis arthropathy
Tomás Dallos, Enijad Sahinbegovic, Elmar Aigner, et al.
Journal of Cell Science
|
April 14, 2011
Elevated Fra-1 expression causes severe lipodystrophy
Julia Luther, Frank Driessler, Matthias Megges, et al.
Rheumatology and Therapy
|
March 30, 2022
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
Annals of the Rheumatic Diseases
|
January 20, 2012
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis
Nicole Reich, Michal Tomcik, Pawel Zerr, et al.
The Journal of Experimental Medicine
|
October 8, 2014
The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells
Bettina Grötsch, Sebastian Brachs, Christiane Lang, et al.
Arthritis and Rheumatism
|
April 29, 2008
Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features
Esther Jimenez-Boj, Nancy Kedersha, Makiyeh Tohidast-Akrad, et al.
RMD Open
|
June 29, 2026
Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity
Alp Temiz, Rita Noversa de Sousa, Janina Schoen, et al.
Scientific Reports
|
May 23, 2020
PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass
Dorothea I H Müller, Cornelia Stoll, Katrin Palumbo-Zerr, et al.
Page
of 101
Search research articles
Search
Showing results (721-730 of 1,009) with videos related to
Sort By:
Page
of 101
The Journal of Biological Chemistry
|
May 27, 2010
Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling
Clarissa S Craft, Wei Zou, Marcus Watkins, et al.
Arthritis and Rheumatism
|
August 20, 2010
Musculoskeletal disease burden of hereditary hemochromatosis
Enijad Sahinbegovic, Tomáš Dallos, Elmar Aigner, et al.
Annals of the Rheumatic Diseases
|
August 4, 2010
Validation of a radiographic scoring system for haemochromatosis arthropathy
Tomás Dallos, Enijad Sahinbegovic, Elmar Aigner, et al.
Journal of Cell Science
|
April 14, 2011
Elevated Fra-1 expression causes severe lipodystrophy
Julia Luther, Frank Driessler, Matthias Megges, et al.
Rheumatology and Therapy
|
March 30, 2022
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
Annals of the Rheumatic Diseases
|
January 20, 2012
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis
Nicole Reich, Michal Tomcik, Pawel Zerr, et al.
The Journal of Experimental Medicine
|
October 8, 2014
The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells
Bettina Grötsch, Sebastian Brachs, Christiane Lang, et al.
Arthritis and Rheumatism
|
April 29, 2008
Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features
Esther Jimenez-Boj, Nancy Kedersha, Makiyeh Tohidast-Akrad, et al.
RMD Open
|
June 29, 2026
Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity
Alp Temiz, Rita Noversa de Sousa, Janina Schoen, et al.
Scientific Reports
|
May 23, 2020
PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass
Dorothea I H Müller, Cornelia Stoll, Katrin Palumbo-Zerr, et al.
Page
of 101